Treatment options for esophageal strictures

Area of Science:

• Gastroenterology
• Oncology
• Medical Devices

Background:

• Esophageal strictures, arising from malignant or benign causes, present a significant clinical challenge.
• Dysphagia is a universal symptom across all esophageal stricture types.
• Current management strategies differ based on stricture etiology and patient prognosis.

Purpose of the Study:

• To review current and novel treatment modalities for esophageal strictures.
• To differentiate between simple and complex benign strictures for predicting recurrence.
• To outline palliation strategies for malignant esophageal strictures.

Main Methods:

• Review of established treatments including stent placement, brachytherapy, and dilation.
• Classification of benign strictures into simple and complex categories.
• Introduction of novel therapies for refractory benign strictures, such as temporary stenting and incisional therapy.

Main Results:

• Stent placement is indicated for malignant strictures with short survival expectancy (≤3 months).
• Brachytherapy offers benefits in dysphagia improvement, complication reduction, and quality of life for malignant strictures with longer survival expectancy (>3 months).
• Dilation is the primary treatment for benign strictures, though complex and refractory cases necessitate advanced interventions.

Conclusions:

• Treatment selection for esophageal strictures hinges on malignancy status, survival, and stricture complexity.
• Distinguishing between simple and complex benign strictures aids in predicting recurrence and guiding therapy.
• Emerging treatments show promise for managing refractory esophageal strictures.